ReShape Lifesciences prices $2.6M public offering of 1.05M shares at $2.50 each

Vyome Holdings, Inc

Offering of 1,054,604 shares closed on June 9, 2025; gross proceeds ~$2.6M.
Proceeds to fund general corporate purposes, including expenses for Vyome merger and asset sale to Ninjour.
Maxim Group LLC acted as sole placement agent; receives 7% cash fee and warrants for 52,730 shares at $2.75.
Shares sold at $2.50 per share; shelf registration filed May 2025 and declared effective May 14, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.